Optimesh Expandable Interbody Fusion System
Device Orthopedics/Orthopedic Surgery
PDI M7403002628
General payments
$2,015,110
Research payments
$335,997
Through program year 2025, $2,015,110 in general payments and $335,997 in research payments were reported against Optimesh Expandable Interbody Fusion System (Orthopedics/Orthopedic Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $560,379 | 1,041 |
| 2024 | General | $535,215 | 1,284 |
| 2024 | Research | $100,000 | 1 |
| 2023 | General | $590,302 | 1,241 |
| 2023 | Research | $108,400 | 5 |
| 2022 | General | $329,215 | 443 |
| 2022 | Research | $127,597 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,009 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.